1. Home
  2. EBF vs PRTC Comparison

EBF vs PRTC Comparison

Compare EBF & PRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ennis Inc.

EBF

Ennis Inc.

HOLD

Current Price

$17.62

Market Cap

436.2M

ML Signal

HOLD

Logo PureTech Health plc

PRTC

PureTech Health plc

N/A

Current Price

$16.79

Market Cap

386.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EBF
PRTC
Founded
1909
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
436.2M
386.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
EBF
PRTC
Price
$17.62
$16.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
227.1K
4.7K
Earning Date
12-22-2025
08-28-2025
Dividend Yield
5.68%
N/A
EPS Growth
3.59
N/A
EPS
1.63
0.20
Revenue
$388,344,000.00
$6,391,000.00
Revenue This Year
$0.96
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$10.82
$7.87
Revenue Growth
N/A
1265.60
52 Week Low
$16.30
$13.30
52 Week High
$22.01
$23.69

Technical Indicators

Market Signals
Indicator
EBF
PRTC
Relative Strength Index (RSI) 61.37 51.25
Support Level $16.51 $16.42
Resistance Level $17.49 $16.83
Average True Range (ATR) 0.33 0.31
MACD 0.12 0.10
Stochastic Oscillator 99.23 58.99

Price Performance

Historical Comparison
EBF
PRTC

About EBF Ennis Inc.

Ennis Inc is a manufacturer and supplier of print products for the wholesale trade. The company's products include advertising specialties, business forms and supplies, commercial printing, eCommerce solutions, envelopes, labels and tags, and folders and packaging. Its products include snap sets, continuous forms, laser cut sheets, tags, labels, envelopes, integrated products, jumbo rolls, and pressure-sensitive products in short, medium and long runs under the following labels: Ennis, Royal Business Forms, Block Graphics, 360 Custom LabelsSM, ColorWorx, Enfusion, among others.

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

Share on Social Networks: